About: Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. The company's lead antiviral drug is BIT225 that is in Phase 2 clinical trial for the treatment of HIV-1, as well as to treat hepatitis C virus infections; and BIT-HBV001 to treat hepatitis B virus and hepatitis delta virus. It also develops preclinical drugs for viral diseases, such as dengue, zika, and influenza virus. The company was incorporated in 1999 and is based in Sydney, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.00 (+100.00%)
BIT ASX Biotron Ltd
Biotron Ltd share price
BIT price activity
Last Price
$0.000
Change (24hr)
0.00 AUD (100.00%)
Volume
1.60M
Volume (4w avg)
-
Open
$0.00
Day Range
$0.00 - $0.00
Previous Close
$0.00
Last Trade
06 Oct, 4:31 am GMT+0
Delayed
06 Oct, 4:31 am GMT+0
BIT price performance
Delayed
06 Oct, 4:31 am GMT+0
BIT Market Signals